Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical OTR4120 for split-thickness skin graft donor-site healing
NL-OMON33585Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2009
- Countries
- 1
01
Overview
Phase 3 trial of RG1192 in burn injury and cutaneous wound (2 arms), sponsored by Erasmus MC. Primary endpoint: Clinical improvement of donor-site wound. Started Jul 2009; status: recruiting.
02
Drugs
RG1192
03
Conditions
burn injurycutaneous wound
Beyond the preview
Go deeper on NL-OMON33585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33585.